Sponsor Spotlight: Portola Pharmaceuticals
Wednesday, November 13, 2019 2:57 PM
KHA is grateful for the support of its Annual Sponsors! Through their generous donations, KHA is better able to support its members and provide a wide array of services. Please join KHA in thanking Diamond Sponsor Portola Pharmaceuticals!
Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers. Founded in 2003 in South San Francisco, California, Portola has operations in the United States and Europe
For more information, visit the Portola Pharmaceuticals website at https://www.portola.com/.
To become a sponsor, contact Claire Arant at KHA (email@example.com).